NCOA3 and polycystic ovary syndrome: Elevated ERα levels, together with increased coactivators such as SRC-2 and SRC-3, may enhance steroid hormone sensitivity and transcriptional activity in the endometrium, thereby contributing to the progression of PCOS-associated endometrial dysfunction.